Volnay Therapeutics is a biotechnology company focused on accelerating the development of gene and cell medicines. It identifies promising therapeutic assets and enabling technologies and provides the resources and operational know-how to advance these initiatives, with emphasis on capital efficiency, economic viability, and innovations in product manufacturing to help bring transformative therapies to patients.
March Biosciences is a clinical-stage biotechnology company specializing in cell therapies for hematological cancers. It focuses on developing CAR-T cell therapies, with its lead product, MB-105, targeting CD5 in refractory T-cell lymphoma and leukemia. The company's approach involves biologically informed target selection, simplified CAR-T engineering, and a streamlined manufacturing process to ensure cell functionality and consistency.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.